💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Ligand Pharmaceuticals Incorporated (LGND)
« Back to company indexLGND Chatter Timeline
Stock Ticker for LGND
Most Active Tweeters for LGND
| User | Tweets |
|---|---|
| @Tickeron | 7 |
| @newsfilterio | 5 |
| @MarketCurrents | 3 |
| @Estimize | 3 |
| @glitchbotio | 2 |
Recent Tweets for LGND
 |
@Tickeron $LGND's Aroon indicator drops into Downtrend on May 7, 2021. View odds for this and other indicators:… https://t.co/yvFskieu7p May 8th 2021, 11:05pm |
 |
@newsfilterio Form SC 13G/A (statement of acquisition of beneficial ownership by individuals) filed with the SEC $LGND https://t.co/c6FDE11B37 May 8th 2021, 8:05pm |
 |
@maxm_profit RT @TradeFlags: TD BUY $LGND at 130.62, Supp 126.48 Resis 152.10 R20 HiLo 37% T1Y 214 buy 2.1 PE 54.4 DIV N/A #Ligand Pha #stocks #trading… May 8th 2021, 2:05pm |
 |
@TradeFlags TD BUY $LGND at 130.62, Supp 126.48 Resis 152.10 R20 HiLo 37% T1Y 214 buy 2.1 PE 54.4 DIV N/A #Ligand Pha #stocks… https://t.co/XFNZvr0Syn May 8th 2021, 3:05am |
|
@Tickeron $LGND's Aroon indicator drops into Downtrend on May 6, 2021. View odds for this and other indicators:… https://t.co/Ff9LAMLn9V May 8th 2021, 1:05am |
 |
@InsiderForms $LGND William BLAIR Investment Management, LLC has filed Form SC 13G/A with SEC. Reporting 7.7% Ownership. Try Ins… https://t.co/YCkGcinAzD May 7th 2021, 8:05pm |
 |
@EdgarInsider SEC Form 10-Q [Quarterly Report] filed by $LGND LIGAND PHARMACEUTICALS INC https://t.co/p3FUdXRIYh May 7th 2021, 2:05am |
 |
@shortablestocks $LGND is short sale restricted for 2021-05-05. https://t.co/Fcyn1vl725 May 5th 2021, 1:05pm |
 |
@Jarvis_Alerts $LGND [Ligand Pharmaceuticals]: Barclays Maintains Overweight Lowers Price Target $198 --> 190 https://t.co/VLz56tPkpQ May 5th 2021, 12:05pm |
 |
@BreakingPttrn $LGND after getting squeezed for months this gapped to the downside. ? https://t.co/yATX5ziX2N May 5th 2021, 11:05am |
 |
@LeeSinTrade1 $LGND Waiting for Buy signal https://t.co/NFQ0c8qmJ7 May 5th 2021, 1:05am |
 |
@egelandd @bjtraderr @IPODave I’ve like $LGND for a long time as well, but without the WSB squeeze train- this one could easi… https://t.co/mTqsoD93j0 May 4th 2021, 11:05pm |
 |
@bjtraderr @IPODave $LGND had solid earnings, the 9% drop is over reaction - looking to scoop up $120s if biotech indeed has no bottom ;) May 4th 2021, 8:05pm |
 |
@mwscott004 @The_Ravid @wallstreetbets It needs a collective effort on one or just a few names $LGND had a 65% short/volume ratio yesterday. May 4th 2021, 6:05pm |
 |
@Harveyoakville #earnings $LGND EPS beat by 40% Revenue up 66% y/y We are a buyer at this level 130-140 Company is actively buying… https://t.co/1KozEjWfh4 May 4th 2021, 4:05pm |
 |
@fda_tracker $LGND New PDUFA Date 2021-07-18 LIGAND PHARMACEUTICALS INCORPORATED Link:https://t.co/QqGYWI4dbT Calendar:https://t.co/sCt1qKoMdr May 4th 2021, 1:05pm |
|
@newsfilterio Ligand Reports First Quarter 2021 Financial Results $LGND https://t.co/Sj77PzIfsl May 4th 2021, 5:05am |
|
@newsfilterio Ligand Pharmaceuticals EPS beats by $0.28, misses on revenue $LGND https://t.co/NT9a5xaYD8 May 4th 2021, 4:05am |
 |
@SiteFocusHQ $LGND Earnings Intelligence Analysis of recent earnings identified Ligand Pharmaceuticals Incorporated (NASDAQ: LGN… https://t.co/L8pHUYUgS0 May 4th 2021, 4:05am |
 |
@EarningsAlley Ligand Pharmaceuticals Incorporated $LGND held an earnings call on 5/3/2021. Here are the highlights: May 4th 2021, 4:05am |
 |
@MichalFutera RT @SeekingAlpha: $LGND - Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q1 2021 Results - Earnings Call Transcript. https:… May 4th 2021, 3:05am |
 |
@SeekingAlpha $LGND - Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q1 2021 Results - Earnings Call Transcript.… https://t.co/b6ayPxdnvm May 4th 2021, 3:05am |
|
@newsfilterio Ligand swings to Q1 profit, but shares fall more than 6% after hours $LGND https://t.co/lLOm3OMTsO May 4th 2021, 12:05am |
 |
@moneymessage_ $LGND - Ligand Pharmaceuticals EPS beats by $0.28, misses on revenue https://t.co/L0KVf8Jj1G May 3rd 2021, 11:05pm |
 |
@Briefingcom $LGND: Ligand Pharma beats by $0.29, misses on revs; reaffirms FY21 EPS guidance, revs guidance https://t.co/4UHkKqlzJA May 3rd 2021, 10:05pm |
 |
@Estimize Great work by Dominantstock who takes the win for $LGND beating 7 other analysts and the Wall Street Consensus - https://t.co/4rBRFTm9iq May 3rd 2021, 8:05pm |
|
@Estimize $LGND beats the Estimize EPS Consensus by 12c and misses the Estimize Revenue Consensus by $9.44M. Reports FQ1 earn… https://t.co/8N4a7iOTEp May 3rd 2021, 8:05pm |
 |
@MarketCurrents $LGND - Ligand swings to Q1 profit, but shares fall more than 6% after hours https://t.co/je5V2W7ET4 May 3rd 2021, 8:05pm |
 |
@realMC_Capital #earnings $LGND -6.38% AH. EPS beat by 25.89% Sales miss by 12.25% May 3rd 2021, 8:05pm |
|
@EdgarInsider FORM 8-K [Press/News Current Report] recently SEC filed. $LGND LIGAND PHARMACEUTICALS INC https://t.co/hVbk5Cx6wG May 3rd 2021, 8:05pm |
 |
@fintel_io $LGND / Ligand Pharmaceuticals files form 8-K - Financial Statements and Exhibits, Results of Operations and Financ… https://t.co/asbtIFHmnH May 3rd 2021, 8:05pm |
 |
@MarcJacksonLA $LGND Ligand Reports First Quarter 2021 Financial Results | Business Wire https://t.co/jbBT67pcSA May 3rd 2021, 8:05pm |
 |
@FlashAlert_me $LGND [15s. delayed]: Issued Press Release on May 03, 16:01:00: Ligand Reports First Quarter 2021 Financial Results https://t.co/hOVMDZQSYX May 3rd 2021, 8:05pm |
 |
@glitchbotio RT @MarketCurrents: $LGND - Ligand Pharmaceuticals EPS beats by $0.28, misses on revenue https://t.co/JyoTjUhmUa May 3rd 2021, 8:05pm |
|
@MarketCurrents $LGND - Ligand Pharmaceuticals EPS beats by $0.28, misses on revenue https://t.co/JyoTjUhmUa May 3rd 2021, 8:05pm |
 |
@StockPods $LGND Earnings Call Today: 4:30 PM EST Webcast: https://t.co/tmwGVW7Rmv Signup for the StockPods BETA now: https://t.co/Vma4E2hQ99 May 3rd 2021, 7:05pm |
|
@Tickeron $LGND reports Earnings today. $LGND in -3.52% Downtrend, sliding for three consecutive days on April 29, 2021. View… https://t.co/YU79oJvLR7 May 3rd 2021, 7:05pm |
 |
@earningsinfo $LGND Ligand Pharmaceuticals Inc Q1 2021 Earnings Call https://t.co/qjF9zfvmSg May 3rd 2021, 7:05pm |
 |
@bthefirsttoknow $LGND: Ligand Pharmaceuticals, Inc. to Host Earnings Call https://t.co/H0ewuTDjyF May 3rd 2021, 6:05pm |
 |
@AccesswireNews $LGND Ligand Pharmaceuticals, Inc. to Host Earnings Call https://t.co/Sx2uNYGWWj May 3rd 2021, 6:05pm |
|
@Estimize $LGND reports after the close, Estimize Consensus +0.18 EPS and +2.04M Revs compared to WS - https://t.co/f0YnwVAUAw May 3rd 2021, 3:05pm |
 |
@StckPro $LGND NEW ARTICLE : Ligand Pharmaceuticals Q1 2021 Earnings Preview https://t.co/M9JaLL3UrA Get all the latest… https://t.co/3uqPeAuUnz May 2nd 2021, 9:05pm |
|
@Tickeron $LGND in -3.52% Downtrend, sliding for three consecutive days on April 29, 2021. View odds for this and other indic… https://t.co/lgOQ0BXdOe May 1st 2021, 6:05pm |
 |
@fintwit_trader @TLPrivate_ Thoughts on $LGND - seems to be tightening up and holding 145. Earning 5/3 I'm sure will move it one wa… https://t.co/90HovyM9w1 April 30th 2021, 6:04pm |
 |
@WVinvest1 $LGND good long term hold good growth & balance sheet https://t.co/LgTM3WOn76 April 30th 2021, 3:04pm |
|
@Tickeron $LGND in -3.52% Downtrend, declining for three consecutive days on April 29, 2021. View odds for this and other ind… https://t.co/Dxkk3BovNH April 30th 2021, 3:04pm |
 |
@ChartMill $LGND was analyzed by 5 analysts. The buy consensus is at 100%. So analysts seem to be very confident about $LGND.… https://t.co/BHlKH6SJEr April 30th 2021, 12:04am |
|
@Harveyoakville $gild $lgnd Gilead #remdesivir https://t.co/iRRHlB8Qe7 April 29th 2021, 5:04am |
|
@newsfilterio Ligand, Lupin settle patent case over Evomela $LGND https://t.co/c8FHeIR88i April 27th 2021, 3:04pm |
|
@glitchbotio RT @MarketCurrents: $LGND - Ligand, Lupin settle patent case over Evomela https://t.co/HqEXP4jFpi April 27th 2021, 3:04pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
